Zhejiang Conba Pharmaceutical (600572.SH) has received two drug registration certificates.
Kang and Betty (600572.SH) issued a statement, the company's wholly-owned subsidiary Zhejiang Jinhua Kang and Betty Biopharmaceutical Co., Ltd...
Zhejiang Conba Pharmaceutical (600572.SH) announced that its wholly-owned subsidiary Zhejiang Jinhua Conba Pharmaceutical Biopharmaceutical Co., Ltd. (referred to as "Jinhua Zhejiang Conba Pharmaceutical") has received the Drug Registration Certificate issued by the National Medical Products Administration for the specifications of 2ml:5mg of Terbutaline Sulfate Nebulization Inhalation Solution and 2ml:0.5mg of Ipratropium Bromide Inhalation Solution.
Related Articles
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
